Covid Inquiry: What have we learnt so far?
The first phase of the Covid Inquiry has come to an end. What have we learnt over the past six weeks?
Similar Posts
SEC charges ex-CEO of medical device company with fraud, says some devices were ‘just a piece of plastic’
The headquarters of the U.S. Securities and Exchange Commission (SEC) is seen in Washington, D.C., May 12, 2021. Andrew Kelly | Reuters Laura Tyler Perryman, co-founder and former CEO of the medical device startup Stimwave Technologies, was charged with allegedly defrauding investors out of $41 million by making “false and misleading” statements about one of…
6 Products To Help Solve The Kinda Private Problems That Older Adults Might Have
Our bodies are constantly changing. And although this experience is universal, sometimes such changes can feel bewildering and even isolating — especially when it comes to figuring out how to cope with issues that are uncomfortable or painful. Luckily, these six products are recommended by thousands of Amazon reviewers and may help alleviate some discomfort,…
Seniors in New York City share New Year’s resolutions for 2024: ‘Never too late’
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
At-home health test maker Thorne explores sale | Reuters News Agency
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….
Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug | Reuters News Agency
Health 25 August 2023, 6:39 pm 1 minute Reuters exclusively reported that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but…
Google reveals the top 10 health searches of 2023 — and experts answer them
Some 35% of U.S. adults have gone online in an attempt to diagnose their health symptoms — and now Google is revealing which conditions they were most curious about this year. The search engine giant has released its annual “Year in Search,” which breaks down the top queries for everything from news and entertainment to…
